Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06972277 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial Comparing the Efficacy of Commercial Weight Management Programs
A NA study, sponsored by WW International.
- Completed
- Registry status
- NA
- Development phase
- 459
- Enrollment target
NCT06972277: Completed NA study, sponsored by WW International.
NCT06972277 is a NA study that has completed, run by WW International. The registered enrollment target is 459 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06972277, a NA study, has completed, sponsored by WW International.
- COMPLETED
- Registry status
- NA
- Development phase
- 459 participants
- Enrollment target
Study Summary
The study compares the effectiveness of three commercial weight management programs. The primary outcome is absolute and percentage weight change at 12-weeks.
Primary Outcome
Measurement of weight using a body weight scale
Interventions
- BEHAVIORAL Commercial weight management program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2026-01-09 |
| Phase | NA |
What the finished NCT06972277 record still lists
NCT06972277 is an interventional study that assigns participants to a tested intervention. The registered 459 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which Commercial weight management program is the first listed.
NCT06972277 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06972277 about?
NCT06972277 is a clinical study titled "A Randomized Controlled Trial Comparing the Efficacy of Commercial Weight Management Programs". The study compares the effectiveness of three commercial weight management programs. The primary outcome is absolute and percentage weight change at 12-weeks.
What is the current status of trial NCT06972277?
This trial is currently completed. It is a NA study. The enrollment target is 459 participants. The study started on 2025-05-14. Estimated completion is 2026-01-09.
What interventions are being tested in trial NCT06972277?
The interventions under investigation include: Commercial weight management program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06972277?
This trial is sponsored by WW International, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06972277's enrollment target sits among peer trials
459 224th of 2000 higher than 1,777 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI